Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Temozolomide plus Stupp regimen in newly diagnosed glioblastoma
NCT05600491Phase 3Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2015
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of temozolomide in glioblastoma multiforme (GBM), oligoastrocytoma, sponsored by Sun Yat-sen University. Started Nov 2015; status: recruiting.
02
Drugs
temozolomide
03
Conditions
glioblastoma multiforme (GBM)oligoastrocytoma
Beyond the preview
Go deeper on NCT05600491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05600491.